BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27920362)

  • 1. A more efficient three-arm non-inferiority test based on pooled estimators of the homogeneous variance.
    Lu H; Jin H; Zeng W
    Stat Methods Med Res; 2018 Aug; 27(8):2437-2446. PubMed ID: 27920362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing non-inferiority of a new treatment in three-arm clinical trials with binary endpoints.
    Tang NS; Yu B; Tang ML
    BMC Med Res Methodol; 2014 Dec; 14():134. PubMed ID: 25524326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blinded sample size re-estimation in three-arm trials with 'gold standard' design.
    Mütze T; Friede T
    Stat Med; 2017 Oct; 36(23):3636-3653. PubMed ID: 28608469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and analysis of three-arm trials with negative binomially distributed endpoints.
    Mütze T; Munk A; Friede T
    Stat Med; 2016 Feb; 35(4):505-21. PubMed ID: 26388314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
    Schwartz TA; Denne JS
    Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the three-arm non-inferiority trial including a placebo with a prespecified margin.
    Hida E; Tango T
    Stat Med; 2011 Feb; 30(3):224-31. PubMed ID: 21213340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian approach for assessing non-inferiority in a three-arm trial with pre-specified margin.
    Ghosh S; Ghosh S; Tiwari RC
    Stat Med; 2016 Feb; 35(5):695-708. PubMed ID: 26434554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.
    Quartagno M; Walker AS; Babiker AG; Turner RM; Parmar MKB; Copas A; White IR
    Trials; 2020 Feb; 21(1):145. PubMed ID: 32029000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When inferiority meets non-inferiority: implications for interim analyses.
    Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
    Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of non-inferiority randomized trials using the difference in restricted mean survival times.
    Weir IR; Trinquart L
    Clin Trials; 2018 Oct; 15(5):499-508. PubMed ID: 30074407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study duration for three-arm non-inferiority survival trials designed for accrual by cohorts.
    Wu Y; Li Y; Hou Y; Li K; Zhou X
    Stat Methods Med Res; 2018 Feb; 27(2):507-520. PubMed ID: 26994213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conducting the non-inferiority test for the means with unknown coefficient of variation in a three-arm trial.
    Lee MC; Wu WY; Lu HY; Hsieh HN; Wu WH
    BMC Med Res Methodol; 2023 Aug; 23(1):183. PubMed ID: 37568109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A framework for testing non-inferiority in a three-arm, sequential, multiple assignment randomized trial.
    Paul E; Chakraborty B; Sikorskii A; Ghosh S
    Stat Methods Med Res; 2024 Apr; 33(4):611-633. PubMed ID: 38400576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choosing and changing the analysis scale in non-inferiority trials with a binary outcome.
    Li Z; Quartagno M; Böhringer S; van Geloven N
    Clin Trials; 2022 Feb; 19(1):14-21. PubMed ID: 34693789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive non-inferiority margins under observable non-constancy.
    Hanscom B; Hughes JP; Williamson BD; Donnell D
    Stat Methods Med Res; 2019; 28(10-11):3318-3332. PubMed ID: 30293490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size reassessment in non-inferiority trials. Internal pilot study designs with ANCOVA.
    Friede T; Kieser M
    Methods Inf Med; 2011; 50(3):237-43. PubMed ID: 20213039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian sample size determination in a three-arm non-inferiority trial with binary endpoints.
    Tang N; Yu B
    J Biopharm Stat; 2022 Sep; 32(5):768-788. PubMed ID: 35213275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
    Lai TL; Shih MC; Zhu G
    Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing non-inferiority: a combination approach.
    Gao P; Ware JH
    Stat Med; 2008 Feb; 27(3):392-406. PubMed ID: 17575568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-inferiority tests for anti-infective drugs using control group quantiles.
    Fay MP; Follmann DA
    Clin Trials; 2016 Dec; 13(6):632-640. PubMed ID: 27430709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.